USA - New York Stock Exchange - NYSE:ATR - US0383361039 - Common Stock
The current stock price of ATR is 123.85 USD. In the past month the price increased by 5.7%. In the past year, price decreased by -19.29%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BALL | BALL CORP | 15.8 | 14.91B | ||
| CCK | CROWN HOLDINGS INC | 13.66 | 12.06B | ||
| SLGN | SILGAN HOLDINGS INC | 10.96 | 4.52B | ||
| GEF.B | GREIF INC-CL B | 23.6 | 3.88B | ||
| GEF | GREIF INC-CL A | 20.82 | 3.42B | ||
| OI | O-I GLASS INC | 11.38 | 2.38B | ||
| TRS | TRIMAS CORP | 16.62 | 1.43B | ||
| MYE | MYERS INDUSTRIES INC | 20 | 733.24M |
AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. The company is headquartered in Crystal Lake, Illinois and currently employs 13,500 full-time employees. The firm serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The company operates in three segments. The Aptar Pharma segment sells proprietary dispensing systems, drug delivery systems, sealing solutions and services for the prescription drug, consumer health care, injectables, active material science solutions and digital health market. The company also specializes in nasal drug delivery for delivering drugs. The Aptar Beauty segment sells dispensing systems and sealing solutions for the beauty, personal care and home care markets. The Aptar Closures segment sells dispensing systems, sealing solutions and food service trays to the food, beverage, personal care, home care, beauty and healthcare markets. This segment also includes the food protection business and the elastomeric flow-control technology business.
APTARGROUP INC
265 Exchange Drive, Suite 301
Crystal Lake ILLINOIS 60014 US
CEO: Stephan B. Tanda
Employees: 13500
Phone: 18154770424
AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. The company is headquartered in Crystal Lake, Illinois and currently employs 13,500 full-time employees. The firm serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The company operates in three segments. The Aptar Pharma segment sells proprietary dispensing systems, drug delivery systems, sealing solutions and services for the prescription drug, consumer health care, injectables, active material science solutions and digital health market. The company also specializes in nasal drug delivery for delivering drugs. The Aptar Beauty segment sells dispensing systems and sealing solutions for the beauty, personal care and home care markets. The Aptar Closures segment sells dispensing systems, sealing solutions and food service trays to the food, beverage, personal care, home care, beauty and healthcare markets. This segment also includes the food protection business and the elastomeric flow-control technology business.
The current stock price of ATR is 123.85 USD. The price increased by 1.15% in the last trading session.
APTARGROUP INC (ATR) has a dividend yield of 1.57%. The yearly dividend amount is currently 1.72.
ATR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
APTARGROUP INC (ATR) operates in the Materials sector and the Containers & Packaging industry.
APTARGROUP INC (ATR) currently has 13500 employees.
The outstanding short interest for APTARGROUP INC (ATR) is 1.87% of its float.
ChartMill assigns a technical rating of 1 / 10 to ATR. When comparing the yearly performance of all stocks, ATR is a bad performer in the overall market: 82.11% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to ATR. ATR has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months ATR reported a non-GAAP Earnings per Share(EPS) of 6. The EPS increased by 12.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.45% | ||
| ROA | 8.22% | ||
| ROE | 15.14% | ||
| Debt/Equity | 0.33 |
12 analysts have analysed ATR and the average price target is 164.22 USD. This implies a price increase of 32.6% is expected in the next year compared to the current price of 123.85.
For the next year, analysts expect an EPS growth of 2.34% and a revenue growth 2.81% for ATR